Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hewett

Showing results (51-60 of 1,735) with videos related to

Pageof 174
Sort By:
Physical Review. D, Particles and Fields|November 1, 1986
Two-body hadronic decays of exotic quarks in E6 theoriesHewett, Rizzo
Physical Review. D, Particles and Fields|April 1, 1987
Fourth-generation and exotic quarkonium in E6 theoriesHewett, Rizzo
Physical Review. D, Particles and Fields|June 1, 1988
Scalar-leptoquark production at hadron collidersHewett, Pakvasa
Prostaglandins & Other Lipid Mediators|January 16, 2008
TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent mannerMary E Hamby, James A Hewett, Sandra J Hewett
Glia|July 8, 2010
Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expressionMary E Hamby, James A Hewett, Sandra J Hewett
Pharmacology & Therapeutics|June 6, 2006
Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous systemSandra J Hewett, Stanley C Bell, James A Hewett
Glia|August 22, 2006
TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2Mary E Hamby, James A Hewett, Sandra J Hewett
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2004
Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic windowJanna M Silakova, James A Hewett, Sandra J Hewett
Epilepsia|January 12, 2011
Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisitionRobert J Claycomb, Sandra J Hewett, James A Hewett
The Journal of Pharmacology and Experimental Therapeutics|September 12, 2006
Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegenerationSandra J Hewett, Janna M Silakova, James A Hewett
Pageof 174

Showing results (51-60 of 1,735) with videos related to

Sort By:
Pageof 174
Physical Review. D, Particles and Fields|November 1, 1986
Two-body hadronic decays of exotic quarks in E6 theoriesHewett, Rizzo
Physical Review. D, Particles and Fields|April 1, 1987
Fourth-generation and exotic quarkonium in E6 theoriesHewett, Rizzo
Physical Review. D, Particles and Fields|June 1, 1988
Scalar-leptoquark production at hadron collidersHewett, Pakvasa
Prostaglandins & Other Lipid Mediators|January 16, 2008
TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent mannerMary E Hamby, James A Hewett, Sandra J Hewett
Glia|July 8, 2010
Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expressionMary E Hamby, James A Hewett, Sandra J Hewett
Pharmacology & Therapeutics|June 6, 2006
Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous systemSandra J Hewett, Stanley C Bell, James A Hewett
Glia|August 22, 2006
TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2Mary E Hamby, James A Hewett, Sandra J Hewett
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2004
Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic windowJanna M Silakova, James A Hewett, Sandra J Hewett
Epilepsia|January 12, 2011
Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisitionRobert J Claycomb, Sandra J Hewett, James A Hewett
The Journal of Pharmacology and Experimental Therapeutics|September 12, 2006
Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegenerationSandra J Hewett, Janna M Silakova, James A Hewett
Pageof 174